Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Vanderbilt University Medical Center · Washington University in St. Louis · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
539
total citations
- FWCI
- 12.15
- Percentile
- 100%
- References
- 58
Citations per year
Authors
31Topics & keywords
Topics
Keywords
- Monoclonal antibody
- Virology
- Coronavirus
- Pandemic
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Antibody
- Coronavirus disease 2019 (COVID-19)
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- HHHelen Hay Whitney Foundation
- VUVanderbilt UniversityAwards: UL1 RR024975-01, TR000445, UL1 RR024975, UL1 TR000445
- MKMerck KGaA
- VUVanderbilt University Medical Center
- NINational Institutes of HealthAwards: 2 UL1 TR000445, NIH T32, T32 AI007151, -0001, COVID-19, 75N93019C00062, RR024975, T32 AI095202, TR000445, UL1 TR000445-06, 2 UL1 TR000445-06, UL1 RR024975-01, UL1 TR000445
- DADefense Advanced Research Projects AgencyAwards: HR0011-18-2-0001, 75N93019C00062
- ESEMD Serono
- ARAdvanced Research Projects Agency
- NINational Institute of Allergy and Infectious DiseasesAwards: T32 AI 095202, 75N93019C0007, 75N93019C00062
- NCNational Center for Research ResourcesAwards: UL1 RR024975, UL1 TR000445, UL1 TR000445-06, RR024975, TR000445, UL1 RR024975-01, 2 UL1 TR000445-06, 1S10RR028106, RR024975-01
- NCNational Center for Advancing Translational SciencesAwards: UL1 TR000445, TR000445, 2 UL1 TR000445-06, 2 UL1 TR000445, UL1 RR024975, UL1 TR000445-06, UL1 RR024975-01